Provided by Tiger Fintech (Singapore) Pte. Ltd.

VolitionRX

0.5115
+0.02054.18%
Post-market: 0.51150.00000.00%19:56 EDT
Volume:623.01K
Turnover:316.10K
Market Cap:50.59M
PE:-1.88
High:0.5200
Open:0.5100
Low:0.4910
Close:0.4910
Loading ...

Chief Scientific Officer Jacob Vincent Micallef Reports Acquisition of Common Shares in VolitionRX Ltd

Reuters
·
20 May

VolitionRX Ltd. CEO Cameron John Reynolds Reports Acquisition of Common Shares

Reuters
·
20 May

VolitionRX (VNRX) Receives a Hold from Benchmark Co.

TIPRANKS
·
19 May

VolitionRX Q1 EPS $(0.06) Up From $(0.10) YoY, Sales $246.38K Up From $171.53K YoY

Benzinga
·
16 May

VolitionRx Ltd. Reports 44% Increase in Q1 2025 Revenue, Reaches Commercial Milestone with Nu.Q® NETs Sales in Europe

Reuters
·
16 May

Press Release: VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update

Dow Jones
·
12 May

BRIEF-VolitionRx Updates Progress Of Nu.Q NETs Test Adoption

Reuters
·
07 May

VolitionRX Limited: Outlines Broad Strategy to Become the 'Nets Company' Worldwide Through Licensing and Updates Progress of Nu.q® Nets Test Adoption

THOMSON REUTERS
·
07 May

VolitionRX Is Maintained at Buy by D. Boral Capital

Dow Jones
·
30 Apr

BRIEF-VolitionRx Ltd May Offer & Sell Shares Of Common Stock Having Offering Price Of Up To $7.5 Mln - SEC Filing

Reuters
·
23 Apr

VolitionRX Signs New Capital Sales Agreement

TIPRANKS
·
23 Apr

VolitionRX Ltd May Offer & Sell Shares of Common Stock Having Offering Price of up to $7.5 Mln Pursuant to Sales Agreement - SEC Filing

THOMSON REUTERS
·
23 Apr

VolitionRX Price Target Maintained With a $2.50/Share by HC Wainwright & Co.

Dow Jones
·
11 Apr

HC Wainwright Initiates VolitionRx With Buy Rating, $2.50 Price Target

MT Newswires Live
·
08 Apr

VolitionRX Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
08 Apr

VolitionRX Ltd (VNRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances

GuruFocus.com
·
01 Apr

BRIEF-Volitionrx Limited Announces Full Fiscal Year 2024 Financial Results And Business Update

Reuters
·
01 Apr

VolitionRX FY Sales $1.200M Miss $1.796M Estimate

Benzinga
·
01 Apr

VolitionRX Limited Announces Full Fiscal Year 2024 Financial Results and Business Update

THOMSON REUTERS
·
01 Apr

VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update

PR Newswire
·
01 Apr